Trial Information
A Phase II Trial of Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Combination with Selinexor for Patients with Newly Diagnosed Multiple Myeloma
Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at
877-664-7724